Vimarsana
Biggest News Aggregation in the World

Page 4 - Active Pharma Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Active Pharma Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Active Pharma Sciences Today - Breaking & Trending Today

Sensex, Nifty snap four day rising streak - Vimarsana News

Sensex, Nifty snap four day rising streak

Domestic indices saw profit taking after rising for four consecutive trading sessions on Tuesday. The Nifty 50 index ended near the 14,850 level. Metal, private banks corrected while media and PSU banks shares advanced. As per the provisional closing data, the barometer index, the S&P BSE Sensex, declined 340.6 points or 0.69% to 49,161.36. The Nifty 50 index fell 91.60 points or 0.61% at 14,850.10. The broader market outperformed the benchmark indices. The S&P BSE Mid-Cap index rose 0.6% while the S&P BSE Small-Cap index added 0.8%. Buyers outpaced sellers. On the BSE, 1,845 shares rose and...

BNP Paribas Arbitrage cuts stake of Solara Active Pharma - Vimarsana News

BNP Paribas Arbitrage cuts stake of Solara Active Pharma

As per the bulk deal data on the NSE, BNP Paribas Arbitrage sold 5,14,463 equity shares or 1.43% stake of Solara Active Pharma Science at Rs 1,463 per share on Monday, 19 April 2021. On the same day, the Scottish Oriental Smaller Companies Trust Plc bought 1,99,259 equity shares or 0.55% stake of Solara Active Pharma Science at Rs 1,462.25 per share via bulk deal on NSE. As of 31 March 2021, BNP Paribas Arbitrage held 3.50% stake in Solara Active Pharma Science. Shares of Solara Active Pharma fell 0.03% to Rs 1,461.30 on BSE. The scrip hit a high of Rs 1,520 and a low of Rs 1,455 so far. On a...

Infosys, JSW Steel, TCS: Top Stocks for Investors on April 12 - Vimarsana News

Infosys, JSW Steel, TCS: Top Stocks for Investors on April 12

Infosys, JSW Steel, TCS: Top Stocks for Investors on April 12 News18 1 hour ago © Provided by News18 Infosys, JSW Steel, TCS: Top Stocks for Investors on April 12 The stock market on Friday, April 9, gave a negative ending after starting the day on a flat note led by banking stocks. Following the same trend, the indices on Monday, April 12, are expected to open lower as the SGX Nifty was trading at 51.00 points or 0.34 percent down at 14,821.00 at 7:05 am. On April 9, the BSE Sensex fell by 154.89 points or 0.31 percent to close at 49,591.32. Similarly, the NSE Nifty lost 38.95 points or...

Source: msn.com
Stocks to watch: TCS, Infosys, Ambuja Cements, NMDC, Balrampur Chini - Vimarsana News

Stocks to watch: TCS, Infosys, Ambuja Cements, NMDC, Balrampur Chini

Here are the top stocks that are likely to be in focus today: Earnings Today: Tata Consultancy Services, HDIL, California Software, Cupid Trades & Finance and Lloyds Metals and Energy will announce their quarterly earnings on April 12. Analysts expect TCS to post 9 per cent YoY growth in March quarter revenue aided by certain large deals such as Postbank and Prudential Financial, ramp-up in multiple $50-100 million deals won in the preceding quarter, and strong demand in areas of cloud and customer experience. Infosys: The company on Sunday said its board will consider a buyback proposal at...

Solara Active Pharma board OKs amalgamation of Aurore, Empyrean and Hydra with co - Vimarsana News

Solara Active Pharma board OKs amalgamation of Aurore, Empyrean and Hydra with co

The board of directors of Solara Active Pharma Sciences on 9 April 2021 approved the amalgamation of Aurore Life Sciences, Empyrean Lifesciences and Hydra Active Pharma Sciences with the company.The combination creates a pure play API company of scale with strong presence in regulated markets, emerging markets, a broad product portfolio, robust operations infrastructure, excellent R&D capabilities and clear synergies to further accelerate growth for the combined entity. The merger is EPS accretive to Solara and will enhance other important financial ratios for Solara. The merger is in line w...